Axogen, Inc. — Director's Dealing 2011

Oct 11, 2011

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: AxoGen, Inc. (LECT)
CIK: 0000805928
Period of Report: 2011-09-30

Reporting Person: Grooms Jamie Mark (Director)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	213079	Direct
Common Stock	132883	Indirect

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock Option	$0.25	2017-12-06	Common Stock (11182)		Direct
Stock Option	$0.25	2017-12-06	Common Stock (3197)		Direct
Stock Option	$0.25	2018-11-18	Common Stock (494)		Direct
Stock Option	$0.25	2020-06-09	Common Stock (108989)		Direct

Footnotes

F1: Pursuant to an Agreement and Plan of Merger, dated as of May 31, 2011, by and among LecTec Corporation ("LecTec"), Nerve Merger Sub Corp., a subsidiary of LecTec ("Merger Sub"), and AxoGen Corporation ("AC"), which the parties amended on June 30, 2011 and August 9, 2011 (as amended, the "Merger Agreement"), Merger Sub merged with and into AC, with AC continuing after the merger as the surviving corporation and a wholly owned subsidiary of LecTec (the "Merger"). The Merger was completed on September 30, 2011, and LecTec was renamed AxoGen, Inc. ("AxoGen"). In connection with the Merger, each share of AC common stock converted into 0.03727336 share of LecTec common stock at the effective time of the Merger.

F2: These shares are directly owned by the Jamie Grooms Trust, of which Mr. Grooms is the trustee.

F3: In connection with the Merger, each option to purchase shares of AC common stock was converted to an option to purchase 0.03727336 of a share of AxoGen common stock.

F4: 9,799 options have vested, and 1,383 options are unvested.

F5: 2,797 options have vested, and 400 options are unvested.

F6: 309 options have vested, and 185 options are unvested.

F7: 27,247 options have vested, and 81,742 options are unvested.

F8: These options vest semi-annually over four years from the date of grant.